ENG and ovarian cancer: However, a longitudinal study of antibody-based microbubbles targeting αvβ3, VEGFR2 or endoglin in xenograft models of breast, pancreatic and ovarian cancer did not show any difference in the performance of αvβ3 and VEGFR2-targeted microbubbles in any model at any time point [34].